AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Sitawow M 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Medicamen Lifesciences Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitawow M 50/1000 Tablet

Diabexe Duo 50/1000 tablets combine two active ingredients to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabexe Duo 50/1000 may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Adherence to your prescribed diet and exercise plan is crucial for effective diabetes control. Common side effects include nausea, vomiting, diarrhea, abdominal distress, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; learn to recognize and manage this condition. This medication is not universally appropriate. Inform your physician of any pre-existing kidney, liver, heart, or pancreatic disorders, or significant alcohol consumption before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Potential drug interactions exist; disclose all medications to your doctor to ensure treatment safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout your treatment.

Primary Ingredients of Sitawow M 50/1000 Tablet

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Sitawow M 50/1000 Tablet

Managing type 2 diabetes

Major Benefits of Sitawow M 50/1000 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Sitawow M 50/1000 Tablet whole; avoid chewing, crushing, or fracturing it. Consume the tablet with food.

Common Side effects of Sitawow M 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitawow M 50/1000 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Sitawow M 50/1000 Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with food.

How Sitawow M 50/1000 Tablet works:

Sitagliptin and metformin, the components of Sitawow M 50/1000 Tablet, work synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This combined action results in superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sitawow M 50/1000 Tablet is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitawow M 50/1000 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitawow M 50/1000 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitawow M 50/1000 Tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of Sitawow M 50/1000 Tablet is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitawow M 50/1000 Tablet :

Should you forget a Sitawow M 50/1000 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitawow M 50/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Sitawow M 50/1000 Tablet

Sitawow M 50/1000 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitawow M 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Sitawow M 50/1000 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Sitawow M 50/1000 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also be avoided by patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitawow M 50/1000 tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitawow M 50/1000 (containing metformin) can cause lactic acidosis, a serious medical emergency resulting from excess lactic acid in the blood (also known as MALA). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitawow M 50/1000 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitawow M 50/1000 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Sitawow M 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitawow M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (Sitawow M 50/1000 Tablet) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitawow M 50/1000 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and prevent access by children, pets, and others.
Sitawow M 50/1000 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitawow M 50/1000 Tablets may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitawow M 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitawow M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (like Sitawow M 50/1000) can rarely cause lactic acidosis, a serious medical emergency with high blood lactic acid levels (also called MALA – Metformin-associated lactic acidosis). This risk is higher in patients with kidney disease, older adults, and heavy alcohol users, so it's avoided in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If these occur, stop taking Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitawow M 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may cause anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitawow M 50/1000 Tablet
162